Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Sexually Transmitted Diseases

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    July 2022
  1. WOOD BR, Guthrie BL
    Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial.
    AIDS. 2022;36:1191-1193.
    PubMed    


    February 2022
  2. ZEGGAGH J, Bauer R, Delaugerre C, Carette D, et al
    Incidence and risk factors for recurrent sexually transmitted infections among men who have sex with men on HIV pre-exposure prophylaxis.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96224.
    PubMed     Abstract available


    January 2022
  3. DE LAZZARI E, Martinez-Mimbrero A, Chivite I, Gonzalez-Cordon A, et al
    Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96240.
    PubMed     Abstract available


  4. JAROLIMOVA J, Platt LR, Curtis MR, Philpotts LL, et al
    Curable sexually transmitted infections among women with HIV in sub-Saharan Africa: systematic review and meta-analysis.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96243.
    PubMed     Abstract available


  5. ODENDAAL LN, Smit DP
    A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection.
    AIDS. 2022;36:155-156.
    PubMed    


    December 2021
  6. CHAUSSADE H, Le-Marec F, Coureau G, Leleux O, et al
    Incidence of lung and HPV-associated malignancies in HIV-infected patients.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96250.
    PubMed     Abstract available


    November 2021
  7. CARLANDER C, Lagheden C, Eklund C, Nordqvist Kleppe S, et al
    Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    AIDS. 2021;35:2367-2374.
    PubMed     Abstract available


    September 2021
  8. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    PubMed     Abstract available


    June 2021
  9. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    PubMed     Abstract available


  10. ANDREIA A, Cappello C, Stirrup O
    High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
    PubMed     Abstract available


    May 2021
  11. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available


    December 2020
  12. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    PubMed     Abstract available


    August 2020
  13. REN M, Szadkowski L, Walmsley SL
    Deciphering the serological response to syphilis treatment in men living with HIV: do we meet the definitions for cure?
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002656.
    PubMed     Abstract available


  14. YUNIHASTUTI E, Teeratakulpisarn N, Jeo WS, Nilasari H, et al
    Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002654.
    PubMed     Abstract available


    July 2020
  15. BERZKALNS AE, Barbee LA, Dombrowski JC, Golden MR, et al
    Low HIV incidence among women following sexually transmitted infection does not support national pre-exposure prophylaxis recommendations.
    AIDS. 2020;34:1429-1431.
    PubMed     Abstract available


    March 2020
  16. TANG EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, et al
    Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002522.
    PubMed     Abstract available


    December 2019
  17. REITSEMA M, Van Hoek AJ, Van Der Loeff MS, Hoornenborg E, et al
    Pre-exposure prophylaxis for msm in the netherlands: impact on hiv and n.gonorrhoeae transmission and cost-effectiveness.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002469.
    PubMed     Abstract available


    August 2019
  18. KREMER WW, Van Zummeren M, Breytenbach E, Richter KL, et al
    The use of molecular markers for cervical screening of women living with hiv in South Africa.
    AIDS. 2019 Aug 2. doi: 10.1097/QAD.0000000000002325.
    PubMed     Abstract available


    July 2019
  19. RICHERT-SPUHLER LE, Pattacini L, Plews M, Irungu E, et al
    Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women.
    AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002323.
    PubMed     Abstract available


    June 2019
  20. FLICK RJ, Simon KR, Nyirenda R, Namachapa K, et al
    The HIV diagnostic assistant: early findings from a novel HIV testing cadre in Malawi.
    AIDS. 2019;33:1215-1224.
    PubMed     Abstract available


    May 2019
  21. MONTANO MA, Dombrowski JC, Dasgupta S, Golden MR, et al
    Differences in STI Risk comparing PrEP users and propensity score-matched historical controls in a clinic setting.
    AIDS. 2019 May 29. doi: 10.1097/QAD.0000000000002281.
    PubMed     Abstract available


  22. DEKKERS BGJ, Bierman WFW, Touw DJ, Alffenaar JC, et al
    Relevance of the drug-drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat.
    AIDS. 2019;33:1100-1102.
    PubMed    


    October 2018
  23. ALDERSLEY J, Lorenz DR, Misra V, Uno H, et al
    Increased risk of anal squamous cell carcinoma in HIV-positive men with prior HBV infection.
    AIDS. 2018 Oct 16. doi: 10.1097/QAD.0000000000002059.
    PubMed     Abstract available


  24. FORD ES, Magaret AS, Spak CW, Selke S, et al
    Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002002.
    PubMed     Abstract available


    September 2018
  25. KENYON C
    We need to consider collateral damage to resistomes when we decide how frequently to screen for chlamydia/gonorrhoea in PrEP cohorts.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002020.
    PubMed     Abstract available


    July 2018
  26. LIU Y, Blakely M, Sigel K, Thin TH, et al
    Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001957.
    PubMed     Abstract available


  27. CLIFFORD GM, Siproudhis L, Piroth L, Poizot-Martin I, et al
    Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001947.
    PubMed     Abstract available


    February 2018
  28. WOOD S, Ratcliffe S, Gowda C, Lee S, et al
    Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001772.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: